Steven Skates
Harvard University
H-index: 76
North America-United States
Top articles of Steven Skates
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Autoantibodies, antigen-autoantibody complexes and antigens complement CA125 for early detection of ovarian cancer | British journal of cancer | Chae Young Han Jacob S Bedia Wei-Lei Yang Sarah J Hawley Lindsay Bergan | 2024/1/9 |
Sialyl-Tn serves as a potential therapeutic target for ovarian cancer | Journal of Ovarian Research | Linah Al-Alem Jillian M Prendergast Justin Clark Bianca Zarrella Dominique T Zarrella | 2024/4/2 |
Abstract A040: Improving specificity for ovarian cancer screening using a novel extracellular vesicle-based blood test | Cancer Research | Emily S Winn-Deen Sanchari Banerjee Daniel Gusenleitner Laura T Bortolin Jonian Grosha | 2024/3/4 |
Normal Risk Ovarian Screening Study: 21-Year Update | Journal of Clinical Oncology | Chae Young Han Karen H Lu Gwen Corrigan Alexandra Perez Sharlene D Kohring | 2024/1/9 |
Creating an Annotated Biospecimen Resource for Liquid Biopsy Applications | Steven J Skates Mark Watson David Elashoff | 2023/8/2 | |
Ultrasensitive detection of circulating LINE-1 ORF1p as a specific multicancer biomarker | Cancer discovery | Martin S Taylor Connie Wu Peter C Fridy Stephanie J Zhang Yasmeen Senussi | 2023/12/12 |
The Normal Risk Ovarian Screening Study (NROSS): Twenty-one year update. | Chae Young Han Karen H Lu Deepak Bedi Enrique Bedia Therese Bartholomew Bevers | 2023/6/1 | |
Ovarian cancer symptoms in pre-clinical invasive epithelial ovarian cancer–An exploratory analysis nested within the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS) | Gynecologic Oncology | James Dilley Aleksandra Gentry-Maharaj Andy Ryan Matthew Burnell Ranjit Manchanda | 2023/12/1 |
The Liquid Biopsy Consortium: Challenges and opportunities for early cancer detection and monitoring | Syeda Maheen Batool Anudeep Yekula Prerna Khanna Tiffaney Hsia Austin S Gamblin | 2023/10/17 | |
Mortality impact, risks, and benefits of general population screening for ovarian cancer: the UKCTOCS randomised controlled trial. | Health Technology Assessment (Winchester, England) | Usha Menon Aleksandra Gentry-Maharaj Matthew Burnell Andy Ryan Jatinderpal K Kalsi | 2023/5/11 |
The avoiding late diagnosis of ovarian cancer (ALDO) project; a pilot national surveillance programme for women with pathogenic germline variants in BRCA1 and BRCA2 | Journal of medical genetics | Sue Philpott Maria Raikou Ranjit Manchanda Michelle Lockley Naveena Singh | 2023/5/1 |
Tumour stage, treatment, and survival of women with high-grade serous tubo-ovarian cancer in UKCTOCS: an exploratory analysis of a randomised controlled trial | The Lancet Oncology | Usha Menon Aleksandra Gentry-Maharaj Matthew Burnell Andy Ryan Naveena Singh | 2023/9/1 |
LINE-1 ORF1p as a candidate biomarker in high grade serous ovarian carcinoma | Scientific reports | Sho Sato Michael Gillette Pamela R de Santiago Eric Kuhn Michael Burgess | 2023/1/27 |
Insights from UKCTOCS for design, conduct and analyses of large randomised controlled trials | Health Technology Assessment | Usha Menon Aleksandra Gentry-Maharaj Matthew Burnell Sophia Apostolidou Andy Ryan | 2023/8/23 |
Internal standard triggered-parallel reaction monitoring mass spectrometry enables multiplexed quantification of candidate biomarkers in plasma | Analytical Chemistry | Jacob J Kennedy Jeffrey R Whiteaker Richard G Ivey Aura Burian Shrabanti Chowdhury | 2022/6/29 |
Extracellular Vesicle-Based Biomarker Assay for the Detection of Early-Stage Ovarian Cancer | J. Clin Oncol | Laura Bortolin Daniel P Salem Jonian Grosha Ibukunoluwapo O Zabroski Sanchari Banerjee | 2022/6/1 |
Mapping the lay of the land: using interactive network analytic tools for collaboration in rural cancer prevention and control | Cancer Epidemiology, Biomarkers & Prevention | Bobbi J Carothers Peg Allen Callie Walsh-Bailey Dixie Duncan Rebeca Vanderburg Pacheco | 2022/6/1 |
Multicancer early detection technologies: a review informed by past cancer screening studies | Sana Raoof Richard J Lee Kunal Jajoo Joseph D Mancias Timothy R Rebbeck | 2022/6/1 | |
Multicancer screening: one size does not fit all | JCO Precision Oncology | Girish Putcha Alberto Gutierrez Steven Skates | 2021/4 |
Completeness and accuracy of national cancer and death registration for outcome ascertainment in trials—an ovarian cancer exemplar | Trials | Jatinderpal K Kalsi Andy Ryan Aleksandra Gentry-Maharaj Danielle Margolin-Crump Naveena Singh | 2021/12 |
